AAIC 2025 Abstract
Beyond p ‐Tau: Unveiling Caspase‐6 Truncated Tau as an Early and Distinct Pathological Marker in Alzheimer's Disease
Study in peopleBiomarkers
Abstract
Background: Alzheimer's disease (AD) is marked by the stereotypical spread of hyperphosphorylated tau ( p ‐tau), which closely correlates with neuronal loss and clinical decline, making it a key disease marker.
